Devendra K Agrawal

Title: Innovations by Devendra K Agrawal

Introduction

Devendra K Agrawal is a notable inventor based in Garden City, NY (US). He has made significant contributions to the field of medical research, particularly in understanding esophageal conditions. With a total of 2 patents to his name, his work focuses on innovative methods for assessing and treating esophageal adenocarcinoma.

Latest Patents

Agrawal's latest patents include systems and methods for Barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers. These methods provide a framework for assessing the risk of developing esophageal adenocarcinoma in a subject using various marker genes and proteins, including ISG15, LTF, CNDP2, DAD1, SET, UBE2N, S100P, and GPI. Additionally, the patents outline methods for determining the expression of esophageal adenocarcinoma risk factors, as well as strategies for treating and preventing the disease. The innovative approaches aim to inhibit the proliferation and migration of esophageal adenocarcinoma cells, thereby increasing susceptibility to cytotoxicity or inducing cell death in these cells.

Career Highlights

Agrawal is currently associated with Prophase Labs, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer treatment and prevention.

Collaborations

Some of his notable coworkers include Sumeet K Mittal and Joe Abdo, who contribute to the collaborative efforts in research and development at Prophase Labs, Inc.

Conclusion

Devendra K Agrawal's contributions to medical research through his patents reflect his commitment to advancing the understanding and treatment of esophageal adenocarcinoma. His innovative methods hold promise for improving patient outcomes in this critical area of health.